REVB Revelation Biosciences, Inc. logo

REVB Revelation Biosciences, Inc.

Healthcare
$1.07-0.93%ClosedMarket Cap: $4.2M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

2

Buy/Sell Ratio

0.00

Net Shares

-23,400

Shares Acquired

0

Shares Disposed

23,400

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 01Zygmont Chester Stanley IIIofficer: Chief Financial OfficerSell13,285$1.1092,063
Fri May 01Rolke Jamesdirector, officer: Chief Executive OfficerSell10,115$1.13214,738
Thu Feb 05Zygmont Chester Stanley IIIofficer: Chief Financial OfficerSell13,100$1.65105,348
Thu Feb 05ROPER JESSdirectorSell1,591$1.8512,828
Thu Feb 05Rolke Jamesdirector, officer: Chief Executive OfficerSell8,521$1.86224,853
Thu Feb 05Chawla Lakhmir SdirectorSell2,261$1.8512,158
Thu Feb 05CARVER JENNIFERdirectorSell1,661$1.8712,758
Mon Jan 12Zygmont Chester Stanley IIIofficer: Chief Financial OfficerSell78,145$0.90473,790
Mon Jan 12ROPER JESSdirectorSell41,981$0.9057,667
Mon Jan 12Rolke Jamesdirector, officer: Chief Executive OfficerSell532,829$0.90933,489
Mon Jan 12Chawla Lakhmir SdirectorSell41,981$0.9057,667
Mon Jan 12CARVER JENNIFERdirectorSell41,981$0.9057,669